跳至主要内容
临床试验/JPRN-UMIN000006343
JPRN-UMIN000006343已完成未知

Assessment of Atrial Late Potentials in Patients with Hypertention to Investigate the Preventive Effect of Eplerenone on Atrial Fibrillation. - Assessment of Atrial Late Potentials in Patients with Hypertention to Investigate the Preventive Effect of Eplerenone on Atrial Fibrillation.

Osaka General Medical Center0 个研究点目标入组 40 人开始时间: 2011年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who have a contraindication to Selara TAB administration. 2. Patients who have a contraindication to Norvasc TAB administration . 3. Patients with liver dysfunction (AST or ALT values of >=100IU). 4. Patients who are judged by the investigator to be not eligible for enrollment in the study.

研究者

相似试验